Daniel Goloe, Ghana, is a PhD candidate in medical sciences at Tel Aviv University, conducting research at the Ella Lemelbaum Institute of Immuno-Oncology at Sheba Medical Center. His research focuses on an mRNA-based CAR-T platform for treating acute myeloid leukemia. He holds a BSc in Agricultural Biotechnology from Kwame Nkrumah University of Science and Technology and an MSc in Marine Biology from the University of Haifa. He is passionate about science, leadership, community engagement, and positive change.